457 related articles for article (PubMed ID: 32264863)
1. Comprehensive routine diagnostic screening to identify predictive mutations, gene amplifications, and microsatellite instability in FFPE tumor material.
Steeghs EMP; Kroeze LI; Tops BBJ; van Kempen LC; Ter Elst A; Kastner-van Raaij AWM; Hendriks-Cornelissen SJB; Hermsen MJW; Jansen EAM; Nederlof PM; Schuuring E; Ligtenberg MJL; Eijkelenboom A
BMC Cancer; 2020 Apr; 20(1):291. PubMed ID: 32264863
[TBL] [Abstract][Full Text] [Related]
2. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.
Giardina T; Robinson C; Grieu-Iacopetta F; Millward M; Iacopetta B; Spagnolo D; Amanuel B
Pathology; 2018 Jun; 50(4):389-401. PubMed ID: 29752127
[TBL] [Abstract][Full Text] [Related]
3. Accurate Pan-Cancer Molecular Diagnosis of Microsatellite Instability by Single-Molecule Molecular Inversion Probe Capture and High-Throughput Sequencing.
Waalkes A; Smith N; Penewit K; Hempelmann J; Konnick EQ; Hause RJ; Pritchard CC; Salipante SJ
Clin Chem; 2018 Jun; 64(6):950-958. PubMed ID: 29632127
[TBL] [Abstract][Full Text] [Related]
4. Copy number changes of clinically actionable genes in melanoma, non-small cell lung cancer and colorectal cancer-A survey across 822 routine diagnostic cases.
Pfarr N; Penzel R; Klauschen F; Heim D; Brandt R; Kazdal D; Jesinghaus M; Herpel E; Schirmacher P; Warth A; Weichert W; Endris V; Stenzinger A
Genes Chromosomes Cancer; 2016 Nov; 55(11):821-33. PubMed ID: 27218826
[TBL] [Abstract][Full Text] [Related]
5. Rare Occurrence of Microsatellite Instability in Gastrointestinal Stromal Tumors.
Park J; Sul HJ; Kim JG
Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33670651
[No Abstract] [Full Text] [Related]
6. Mutation Burden and I Index for Detection of Microsatellite Instability in Colorectal Cancer by Targeted Next-Generation Sequencing.
Kim JE; Chun SM; Hong YS; Kim KP; Kim SY; Kim J; Sung CO; Cho EJ; Kim TW; Jang SJ
J Mol Diagn; 2019 Mar; 21(2):241-250. PubMed ID: 30389464
[TBL] [Abstract][Full Text] [Related]
7. Tumour mutational burden, microsatellite instability, and actionable alterations in metastatic colorectal cancer: Next-generation sequencing results of TRIBE2 study.
Antoniotti C; Korn WM; Marmorino F; Rossini D; Lonardi S; Masi G; Randon G; Conca V; Boccaccino A; Tomasello G; Passardi A; Swensen J; Ugolini C; Oberley M; Tamburini E; Casagrande M; Domenyuk V; Fontanini G; Giordano M; Abraham J; Spetzler D; Falcone A; Lenz HJ; Cremolini C
Eur J Cancer; 2021 Sep; 155():73-84. PubMed ID: 34365081
[TBL] [Abstract][Full Text] [Related]
8. Quantitative evaluation of MSI testing using NGS detects the imperceptible microsatellite changed caused by MSH6 deficiency.
Yamamoto G; Takenoya T; Takahashi A; Osanai Y; Kakuta M; Tachikawa T; Washio T; Kamiyama M; Shiibashi M; Yamaguchi S; Akagi K
Fam Cancer; 2021 Apr; 20(2):137-143. PubMed ID: 32949329
[TBL] [Abstract][Full Text] [Related]
9. Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients.
Malapelle U; Mayo de-Las-Casas C; Rocco D; Garzon M; Pisapia P; Jordana-Ariza N; Russo M; Sgariglia R; De Luca C; Pepe F; Martinez-Bueno A; Morales-Espinosa D; González-Cao M; Karachaliou N; Viteri Ramirez S; Bellevicine C; Molina-Vila MA; Rosell R; Troncone G
Br J Cancer; 2017 Mar; 116(6):802-810. PubMed ID: 28170370
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous detection of clinically relevant mutations and amplifications for routine cancer pathology.
Hoogstraat M; Hinrichs JW; Besselink NJ; Radersma-van Loon JH; de Voijs CM; Peeters T; Nijman IJ; de Weger RA; Voest EE; Willems SM; Cuppen E; Koudijs MJ
J Mol Diagn; 2015 Jan; 17(1):10-8. PubMed ID: 25445215
[TBL] [Abstract][Full Text] [Related]
11. Validation of a Circulating Tumor DNA-Based Next-Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing.
Al Zoughbi W; Fox J; Beg S; Papp E; Hissong E; Ohara K; Keefer L; Sigouros M; Kane T; Bockelman D; Nichol D; Patchell E; Bareja R; Karandikar A; Alnajar H; Cerqueira G; Guthrie VB; Verner E; Manohar J; Greco N; Wilkes D; Tagawa S; Malbari MS; Holcomb K; Eng KW; Shah M; Altorki NK; Sboner A; Nanus D; Faltas B; Sternberg CN; Simmons J; Houvras Y; Molina AM; Angiuoli S; Elemento O; Mosquera JM
Oncologist; 2021 Nov; 26(11):e1971-e1981. PubMed ID: 34286887
[TBL] [Abstract][Full Text] [Related]
12. A novel NGS-based microsatellite instability (MSI) status classifier with 9 loci for colorectal cancer patients.
Zheng K; Wan H; Zhang J; Shan G; Chai N; Li D; Fang N; Liu L; Zhang J; Du R; Wu Q; Li X; Zhang C
J Transl Med; 2020 May; 18(1):215. PubMed ID: 32466784
[TBL] [Abstract][Full Text] [Related]
13. Microsatellite instability detection using a large next-generation sequencing cancer panel across diverse tumour types.
Pang J; Gindin T; Mansukhani M; Fernandes H; Hsiao S
J Clin Pathol; 2020 Feb; 73(2):83-89. PubMed ID: 31530574
[TBL] [Abstract][Full Text] [Related]
14. Tumor molecular profiling of NSCLC patients using next generation sequencing.
Tsoulos N; Papadopoulou E; Metaxa-Mariatou V; Tsaousis G; Efstathiadou C; Tounta G; Scapeti A; Bourkoula E; Zarogoulidis P; Pentheroudakis G; Kakolyris S; Boukovinas I; Papakotoulas P; Athanasiadis E; Floros T; Koumarianou A; Barbounis V; Dinischiotu A; Nasioulas G
Oncol Rep; 2017 Dec; 38(6):3419-3429. PubMed ID: 29130105
[TBL] [Abstract][Full Text] [Related]
15. Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health Service.
Hamblin A; Wordsworth S; Fermont JM; Page S; Kaur K; Camps C; Kaisaki P; Gupta A; Talbot D; Middleton M; Henderson S; Cutts A; Vavoulis DV; Housby N; Tomlinson I; Taylor JC; Schuh A
PLoS Med; 2017 Feb; 14(2):e1002230. PubMed ID: 28196074
[TBL] [Abstract][Full Text] [Related]
16. A robust microsatellite instability detection model for unpaired colorectal cancer tissue samples.
Zhang Z; Wan H; Xu B; He H; Shan G; Zhang J; Wu Q; Li T
Chin Med J (Engl); 2023 May; 136(9):1082-1088. PubMed ID: 37022939
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a Hybrid Capture-Based Pan-Cancer Panel for Analysis of Treatment Stratifying Oncogenic Aberrations and Processes.
Kroeze LI; de Voer RM; Kamping EJ; von Rhein D; Jansen EAM; Hermsen MJW; Barberis MCP; Botling J; Garrido-Martin EM; Haller F; Lacroix L; Maes B; Merkelbach-Bruse S; Pestinger V; Pfarr N; Stenzinger A; van den Heuvel MM; Grünberg K; Ligtenberg MJL
J Mol Diagn; 2020 Jun; 22(6):757-769. PubMed ID: 32205293
[TBL] [Abstract][Full Text] [Related]
18. Microsatellite instability detection by next generation sequencing.
Salipante SJ; Scroggins SM; Hampel HL; Turner EH; Pritchard CC
Clin Chem; 2014 Sep; 60(9):1192-9. PubMed ID: 24987110
[TBL] [Abstract][Full Text] [Related]
19. Detection of Microsatellite Instability Biomarkers via Next-Generation Sequencing.
Bonneville R; Krook MA; Chen HZ; Smith A; Samorodnitsky E; Wing MR; Reeser JW; Roychowdhury S
Methods Mol Biol; 2020; 2055():119-132. PubMed ID: 31502149
[TBL] [Abstract][Full Text] [Related]
20. A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors.
Luthra R; Patel KP; Routbort MJ; Broaddus RR; Yau J; Simien C; Chen W; Hatfield DZ; Medeiros LJ; Singh RR
J Mol Diagn; 2017 Mar; 19(2):255-264. PubMed ID: 28017569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
